Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A

被引:43
作者
Cheng, HY
Lin, TC
Yang, CM
Wang, KC
Lin, CC
机构
[1] Kaohsiung Med Univ, Coll Pharm, Grad Inst Pharmaceut Sci, Kaohsiung 807, Taiwan
[2] Tajen Inst Technol, Dept Pharm, Pingtung 907, Taiwan
[3] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung 807, Taiwan
关键词
antiviral activity; HSV-2; ptcrocarnin A; modes of action;
D O I
10.1016/j.micinf.2004.03.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purpose of this study was to investigate the in vitro antiviral properties of pterocarnin A. extracted from the bark of Pterocarya stenoptera (Juylandaceae). Results showed that pterocarnin A exhibited anti-herpes simplex virus (HSV) activity. It had a low selectivity index (SI) value and only possessed some level of cell cytotoxic effect at high antiviral concentrations. Mechanism studies demonstrated that pterocarnin A inhibited herpes simplex virus type 2 (HSV-2) from attaching and penetrating into cells. It also actively Suppressed HSV-2 multiplication in Vero cells even when added 12 h after infection. This observation indicated that pterocarnin A affected the late stage(s) of HSV-2 infection cycle. Pterocarnin A also significantly reduced viral infectivity at high concentrations. From these observations, it was concluded that pterocarnin A suppressed both early and late in the replication cycle of HSV-2. The various modes of action of pterocarnin A in interfering, with certain steps of viral infection thus merit further investigation. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:738 / 744
页数:7
相关论文
共 50 条
  • [11] Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
    James, Scott H.
    Prichard, Mark N.
    CURRENT OPINION IN VIROLOGY, 2014, 8 : 54 - 61
  • [12] Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2
    Luo, Chenhong
    Goshima, Fumi
    Kamakura, Maki
    Mutoh, Yoshifumi
    Iwata, Seiko
    Kimura, Hiroshi
    Nishiyama, Yukihiro
    FRONTIERS IN MICROBIOLOGY, 2012, 3
  • [13] Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
    Michaelis, Martin
    Kleinschmidt, Malte C.
    Bojkova, Denisa
    Rabenau, Holger F.
    Wass, Mark N.
    Cinatl, Jindrich, Jr.
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [14] Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2
    Zhang, Hao
    Feng, Hai
    Luo, Lingqi
    Zhou, Qi
    Luo, Zhijun
    Peng, Yihong
    VIRUS RESEARCH, 2010, 150 (1-2) : 22 - 27
  • [15] Seroprevalences of herpes simplex virus type 2 and Chlamydia trachomatis in Turkey
    Işıl Maral
    Aydan Biri
    Ümit Korucuoğlu
    Coşkun Bakar
    Meltem Çırak
    M. Ali Bumin
    Archives of Gynecology and Obstetrics, 2009, 280 : 739 - 743
  • [16] Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection
    Karim, Salim S. Abdool
    Karim, Quarraisha Abdool
    Kharsany, Ayesha B. M.
    Baxter, Cheryl
    Grobler, Anneke C.
    Werner, Lise
    Kashuba, Angela
    Mansoor, Leila E.
    Samsunder, Natasha
    Mindel, Adrian
    Gengiah, Tanuja N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06) : 530 - 539
  • [17] Seroprevalences of herpes simplex virus type 2 and Chlamydia trachomatis in Turkey
    Maral, Isil
    Biri, Aydan
    Korucuoglu, Uemit
    Bakar, Coskun
    Cirak, Meltem
    Bumin, M. Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (05) : 739 - 743
  • [18] Mollaret's meningitis and herpes simplex virus type 2 infections
    Farazmand, P.
    Woolley, P. D.
    Kinghorn, G. R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (06) : 306 - 307
  • [19] Seroepidemiology of Herpes Simplex Virus Type 1 and 2 in Northern Iran
    Rezaei-Chaparpordi, S.
    Assmar, M.
    Amirmozafari, N.
    Modiri, L.
    Massiha, A.
    Shokri-Fashtali, S.
    Gholizadeh, Z.
    Akbari, S.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2012, 41 (08) : 75 - 79
  • [20] PASSIVE TRANSFER OF ANTI-HERPES-SIMPLEX VIRUS TYPE-2 MONOCLONAL AND POLYCLONAL ANTIBODIES PROTECT AGAINST HERPES-SIMPLEX VIRUS TYPE-1-INDUCED BUT NOT HERPES-SIMPLEX VIRUS TYPE-2-INDUCED STROMAL KERATITIS
    RITCHIE, MH
    OAKES, JE
    LAUSCH, RN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (08) : 2460 - 2468